Document is current

Any future updates will be listed below

Low numbers of blood and salivary natural killer cells are associated with a better response to belimumab in primary Sjögren’s syndrome: results of the BELISS study

Crossref DOI link: https://doi.org/10.1186/s13075-015-0750-y

Published Online: 2015-09-04

Published Print: 2015-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark